| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
|
|
|
|||||||
|
|||||||||
Published online before print July 1, 2003
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Department of Immunology, The Scripps Research Institute, La Jolla, California
1Correspondence: The Scripps Research Institute, 10550 North Torrey Pines Road, La Jolla, CA 92037. E-mail: bruce{at}scripps.edu
Macrophages and dendritic cells are in the front line of host defense. When they sense host invasion, they produce cytokines that alert other innate immune cells and also abet the development of an adaptive immune response. Although lipolysaccharide (LPS), peptidoglycan, unmethylated DNA, and other microbial products were long known to be the primary targets of innate immune recognition, there was puzzlement as to how each molecule triggered a response. It is now known that the Toll-like receptors (TLRs) are the principal signaling molecules through which mammals sense infection. Each TLR recognizes a restricted subset of molecules produced by microbes, and in some circumstances, only a single type of molecule is sensed (e.g., only LPS is sensed by TLR4). TLRs direct the activation of immune cells near to and far from the site of infection, mobilizing the comparatively vast immune resources of the host to confine and defeat an invasive organism before it has become widespread. The biochemical details of TLR signaling have been analyzed through forward and reverse genetic methods, and full elucidation of the molecular interactions that transpire within the first minutes following contact between host and pathogen will soon be at hand.
Key Words: lipopolysaccharide • MD-2 molecule • interleukin-1 • TNF • infection • sepsis • adjuvant • interferon • innate immunity
This article has been cited by other articles:
|
|
 |
|
  M. M. Wurfel, A. C. Gordon, T. D. Holden, F. Radella, J. Strout, O. Kajikawa, J. T. Ruzinski, G. Rona, R. A. Black, S. Stratton, et al. Toll-like Receptor 1 Polymorphisms Affect Innate Immune Responses and Outcomes in Sepsis Am. J. Respir. Crit. Care Med., October 1, 2008; 178(7): 710 - 720. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 G. Fedele, M. Nasso, F. Spensieri, R. Palazzo, L. Frasca, M. Watanabe, and C. M. Ausiello Lipopolysaccharides from Bordetella pertussis and Bordetella parapertussis Differently Modulate Human Dendritic Cell Functions Resulting in Divergent Prevalence of Th17-Polarized Responses J. Immunol., July 1, 2008; 181(1): 208 - 216. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 T. G. Loof, O. Goldmann, and E. Medina Immune Recognition of Streptococcus pyogenes by Dendritic Cells Infect. Immun., June 1, 2008; 76(6): 2785 - 2792. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 W.-J. Lee Bacterial-Modulated Signaling Pathways in Gut Homeostasis Sci. Signal., May 27, 2008; 1(21): pe24 - pe24. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. Vasl, P. Prohinar, T. L. Gioannini, J. P. Weiss, and R. Jerala Functional Activity of MD-2 Polymorphic Variant Is Significantly Different in Soluble and TLR4-Bound Forms: Decreased Endotoxin Binding by G56R MD-2 and Its Rescue by TLR4 Ectodomain J. Immunol., May 1, 2008; 180(9): 6107 - 6115. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. Hasiwa, O. Kylian, T. Hartung, and F. Rossi Removal of immune-stimulatory components from surfaces by plasma discharges Innate Immunity, April 1, 2008; 14(2): 89 - 97. [Abstract] [PDF]
|
|
|
|
 |
|
 P. F. Bradfield, C. A. Johnson-Leger, C. Zimmerli, and B. A. Imhof LPS differentially regulates adhesion and transendothelial migration of human monocytes under static and flow conditions Int. Immunol., February 1, 2008; 20(2): 247 - 257. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. Eken, O. Gasser, G. Zenhaeusern, I. Oehri, C. Hess, and J. A. Schifferli Polymorphonuclear Neutrophil-Derived Ectosomes Interfere with the Maturation of Monocyte-Derived Dendritic Cells J. Immunol., January 15, 2008; 180(2): 817 - 824. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 K. P. Mollen, R. M. Levy, J. M. Prince, R. A. Hoffman, M. J. Scott, D. J. Kaczorowski, R. Vallabhaneni, Y. Vodovotz, and T. R. Billiar Systemic inflammation and end organ damage following trauma involves functional TLR4 signaling in both bone marrow-derived cells and parenchymal cells J. Leukoc. Biol., January 1, 2008; 83(1): 80 - 88. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 B. Salaun, S. Lebecque, S. Matikainen, D. Rimoldi, and P. Romero Toll-like Receptor 3 Expressed by Melanoma Cells as a Target for Therapy? Clin. Cancer Res., August 1, 2007; 13(15): 4565 - 4574. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
T. Reimer, M. Schweizer, and T. W. Jungi Type I IFN Induction in Response to Listeria monocytogenes in Human Macrophages: Evidence for a Differential Activation of IFN Regulatory Factor 3 (IRF3) J. Immunol., July 15, 2007; 179(2): 1166 - 1177. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
B. J. Leppert, J. M. Mansfield, and D. M. Paulnock The Soluble Variant Surface Glycoprotein of African Trypanosomes Is Recognized by a Macrophage Scavenger Receptor and Induces I{kappa}B{alpha} Degradation Independently of TRAF6-Mediated TLR Signaling J. Immunol., July 1, 2007; 179(1): 548 - 556. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R. Zolfaghari, C. J. Cifelli, S. O. Lieu, Q. Chen, N.-q. Li, and A. C. Ross Lipopolysaccharide opposes the induction of CYP26A1 and CYP26B1 gene expression by retinoic acid in the rat liver in vivo Am J Physiol Gastrointest Liver Physiol, April 1, 2007; 292(4): G1029 - G1036. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 I. A. Schepetkin, L. N. Kirpotina, A. I. Khlebnikov, and M. T. Quinn High-Throughput Screening for Small-Molecule Activators of Neutrophils: Identification of Novel N-Formyl Peptide Receptor Agonists Mol. Pharmacol., April 1, 2007; 71(4): 1061 - 1074. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. Pevsner-Fischer, V. Morad, M. Cohen-Sfady, L. Rousso-Noori, A. Zanin-Zhorov, S. Cohen, I. R. Cohen, and D. Zipori Toll-like receptors and their ligands control mesenchymal stem cell functions Blood, February 15, 2007; 109(4): 1422 - 1432. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
G. Elson, I. Dunn-Siegrist, B. Daubeuf, and J. Pugin Contribution of Toll-like receptors to the innate immune response to Gram-negative and Gram-positive bacteria Blood, February 15, 2007; 109(4): 1574 - 1583. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. T. Benjamin, R. J. Smith, B. A. Halloran, T. J. Day, D. R. Kelly, and L. S. Prince FGF-10 is decreased in bronchopulmonary dysplasia and suppressed by Toll-like receptor activation Am J Physiol Lung Cell Mol Physiol, February 1, 2007; 292(2): L550 - L558. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. Tabiasco, E. Devevre, N. Rufer, B. Salaun, J.-C. Cerottini, D. Speiser, and P. Romero Human Effector CD8+ T Lymphocytes Express TLR3 as a Functional Coreceptor J. Immunol., December 15, 2006; 177(12): 8708 - 8713. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
H.-F. Bu, X. Wang, Y.-Q. Zhu, R. Y. Williams, W. Hsueh, X. Zheng, R. A. Rozenfeld, X.-L. Zuo, and X.-D. Tan Lysozyme-Modified Probiotic Components Protect Rats against Polymicrobial Sepsis: Role of Macrophages and Cathelicidin-Related Innate Immunity J. Immunol., December 15, 2006; 177(12): 8767 - 8776. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 N. Gill, P. M. Deacon, B. Lichty, K. L. Mossman, and A. A. Ashkar Induction of Innate Immunity against Herpes Simplex Virus Type 2 Infection via Local Delivery of Toll-Like Receptor Ligands Correlates with Beta Interferon Production. J. Virol., October 1, 2006; 80(20): 9943 - 9950. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R. M. Levy, J. M. Prince, R. Yang, K. P. Mollen, H. Liao, G. A. Watson, M. P. Fink, Y. Vodovotz, and T. R. Billiar Systemic inflammation and remote organ damage following bilateral femur fracture requires Toll-like receptor 4 Am J Physiol Regulatory Integrative Comp Physiol, October 1, 2006; 291(4): R970 - R976. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 X. Tang, D. Metzger, S. Leeman, and S. Amar LPS-induced TNF-{alpha} factor (LITAF)-deficient mice express reduced LPS-induced cytokine: Evidence for LITAF-dependent LPS signaling pathways PNAS, September 12, 2006; 103(37): 13777 - 13782. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. S. Kristof, J. Fielhaber, A. Triantafillopoulos, S. Nemoto, and J. Moss Phosphatidylinositol 3-Kinase-dependent Suppression of the Human Inducible Nitric-oxide Synthase Promoter Is Mediated by FKHRL1 J. Biol. Chem., August 18, 2006; 281(33): 23958 - 23968. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. P. Wiertsema, S.-K. Khoo, G. Baynam, R. H. Veenhoven, I. A. Laing, G. A. Zielhuis, G. T. Rijkers, J. Goldblatt, P. N. LeSouef, and E. A. M. Sanders Association of CD14 Promoter Polymorphism with Otitis Media and Pneumococcal Vaccine Responses. Clin. Vaccine Immunol., August 1, 2006; 13(8): 892 - 897. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
P. Yu, U. Wellmann, S. Kunder, L. Quintanilla-Martinez, L. Jennen, N. Dear, K. Amann, S. Bauer, T. H. Winkler, and H. Wagner Toll-like receptor 9-independent aggravation of glomerulonephritis in a novel model of SLE Int. Immunol., August 1, 2006; 18(8): 1211 - 1219. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
Z. Jiang, P. Georgel, C. Li, J. Choe, K. Crozat, S. Rutschmann, X. Du, T. Bigby, S. Mudd, S. Sovath, et al. Details of Toll-like receptor:adapter interaction revealed by germ-line mutagenesis PNAS, July 18, 2006; 103(29): 10961 - 10966. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. E. Medvedev, I. Sabroe, J. D. Hasday, and S. N. Vogel Invited review: Tolerance to microbial TLR ligands: molecular mechanisms and relevance to disease Innate Immunity, June 1, 2006; 12(3): 133 - 150. [Abstract] [PDF]
|
|
|
|
|
|
L. E. Cole, K. L. Elkins, S. M. Michalek, N. Qureshi, L. J. Eaton, P. Rallabhandi, N. Cuesta, and S. N. Vogel Immunologic Consequences of Francisella tularensis Live Vaccine Strain Infection: Role of the Innate Immune Response in Infection and Immunity. J. Immunol., June 1, 2006; 176(11): 6888 - 6899. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. Totemeyer, M. Sheppard, A. Lloyd, D. Roper, C. Dowson, D. Underhill, P. Murray, D. Maskell, and C. Bryant IFN-{gamma} Enhances Production of Nitric Oxide from Macrophages via a Mechanism That Depends on Nucleotide Oligomerization Domain-2. J. Immunol., April 15, 2006; 176(8): 4804 - 4810. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
B. Salaun, I. Coste, M.-C. Rissoan, S. J. Lebecque, and T. Renno TLR3 Can Directly Trigger Apoptosis in Human Cancer Cells. J. Immunol., April 15, 2006; 176(8): 4894 - 4901. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S.J. Challacombe and J.R. Naglik The Effects of HIV Infection on Oral Mucosal Immunity Adv. Dent. Res., April 1, 2006; 19(1): 29 - 35. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
Q. Pan, V. Kravchenko, A. Katz, S. Huang, M. Ii, J. C. Mathison, K. Kobayashi, R. A. Flavell, R. D. Schreiber, D. Goeddel, et al. NF-{kappa}B-Inducing Kinase Regulates Selected Gene Expression in the Nod2 Signaling Pathway Infect. Immun., April 1, 2006; 74(4): 2121 - 2127. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S.J. Challacombe and J.R. Naglik The Effects of HIV Infection on Oral Mucosal Immunity Advances in Dental Research, April 1, 2006; 19(1): 29 - 35. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 L. M. Kreckler, T. C. Wan, Z.-D. Ge, and J. A. Auchampach Adenosine Inhibits Tumor Necrosis Factor-{alpha} Release from Mouse Peritoneal Macrophages via A2A and A2B but Not the A3 Adenosine Receptor J. Pharmacol. Exp. Ther., April 1, 2006; 317(1): 172 - 180. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 E. L. Cooper Role of TOLL-like Receptors in Adjuvant-Augmented Immune Therapies by T. Seya. Evid. Based Complement. Altern. Med., March 1, 2006; 3(1): 133 - 137. [Full Text] [PDF]
|
|
|
|
|
|
M. Muthukuru and C. W. Cutler Upregulation of Immunoregulatory Src Homology 2 Molecule Containing Inositol Phosphatase and Mononuclear Cell Hyporesponsiveness in Oral Mucosa during Chronic Periodontitis Infect. Immun., February 1, 2006; 74(2): 1431 - 1435. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. C. Tydell, J. Yuan, P. Tran, and M. E. Selsted Bovine Peptidoglycan Recognition Protein-S: Antimicrobial Activity, Localization, Secretion, and Binding Properties J. Immunol., January 15, 2006; 176(2): 1154 - 1162. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
W. Vermi, F. Facchetti, E. Riboldi, H. Heine, S. Scutera, S. Stornello, D. Ravarino, P. Cappello, M. Giovarelli, R. Badolato, et al. Role of dendritic cell-derived CXCL13 in the pathogenesis of Bartonella henselae B-rich granuloma Blood, January 15, 2006; 107(2): 454 - 462. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. M. Newman, P. Salunkhe, A. Godzik, and J. C. Reed Identification and Characterization of a Novel Bacterial Virulence Factor That Shares Homology with Mammalian Toll/Interleukin-1 Receptor Family Proteins Infect. Immun., January 1, 2006; 74(1): 594 - 601. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. Herath, D. P. Fischer, D. Werling, E. J. Williams, S. T. Lilly, H. Dobson, C. E. Bryant, and I. M. Sheldon Expression and Function of Toll-Like Receptor 4 in the Endometrial Cells of the Uterus Endocrinology, January 1, 2006; 147(1): 562 - 570. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. V. Grishin, J. Wang, D. A. Potoka, D. J. Hackam, J. S. Upperman, P. Boyle, R. Zamora, and H. R. Ford Lipopolysaccharide Induces Cyclooxygenase-2 in Intestinal Epithelium via a Noncanonical p38 MAPK Pathway J. Immunol., January 1, 2006; 176(1): 580 - 588. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. Knapp, C. W. Wieland, S. Florquin, R. Pantophlet, L. Dijkshoorn, N. Tshimbalanga, S. Akira, and T. van der Poll Differential Roles of CD14 and Toll-like Receptors 4and 2 in Murine Acinetobacter Pneumonia Am. J. Respir. Crit. Care Med., January 1, 2006; 173(1): 122 - 129. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
P. B. Mann, D. Wolfe, E. Latz, D. Golenbock, A. Preston, and E. T. Harvill Comparative Toll-Like Receptor 4-Mediated Innate Host Defense to Bordetella Infection Infect. Immun., December 1, 2005; 73(12): 8144 - 8152. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
G. S. Kirimanjeswara, P. B. Mann, M. Pilione, M. J. Kennett, and E. T. Harvill The Complex Mechanism of Antibody-Mediated Clearance of Bordetella from the Lungs Requires TLR4 J. Immunol., December 1, 2005; 175(11): 7504 - 7511. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. Kumar, A. Roychowdhury, B. Ember, Q. Wang, R. Guan, R. A. Mariuzza, and G.-J. Boons Selective Recognition of Synthetic Lysine and meso-Diaminopimelic Acid-type Peptidoglycan Fragments by Human Peptidoglycan Recognition Proteins I{alpha} and S J. Biol. Chem., November 4, 2005; 280(44): 37005 - 37012. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. A. Hughes, C. S. Green, L. Lowchyj, G. M. Lee, V. K. Grippe, M. F. Smith Jr., L.-Y. Huang, E. T. Harvill, and T. J. Merkel MyD88-Dependent Signaling Contributes to Protection following Bacillus anthracis Spore Challenge of Mice: Implications for Toll-Like Receptor Signaling Infect. Immun., November 1, 2005; 73(11): 7535 - 7540. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. S. Hadley, J. E. Wang, S. J. Foster, C. Thiemermann, and C. J. Hinds Peptidoglycan of Staphylococcus aureus Upregulates Monocyte Expression of CD14, Toll-Like Receptor 2 (TLR2), and TLR4 in Human Blood: Possible Implications for Priming of Lipopolysaccharide Signaling Infect. Immun., November 1, 2005; 73(11): 7613 - 7619. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
O. Pino, M. Martin, and S. M. Michalek Cellular Mechanisms of the Adjuvant Activity of the Flagellin Component FljB of Salmonella enterica Serovar Typhimurium To Potentiate Mucosal and Systemic Responses Infect. Immun., October 1, 2005; 73(10): 6763 - 6770. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
K. B. Goralski, D. Abdulla, C. J. Sinal, A. Arsenault, and K. W. Renton Toll-like receptor-4 regulation of hepatic Cyp3a11 metabolism in a mouse model of LPS-induced CNS inflammation Am J Physiol Gastrointest Liver Physiol, September 1, 2005; 289(3): G434 - G443. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. B. Hinckley, C. M. Reynolds, A. A. Ribeiro, S. C. McGrath, R. J. Cotter, F. N. Lauw, D. T. Golenbock, and C. R. H. Raetz A Leptospira interrogans Enzyme with Similarity to Yeast Ste14p That Methylates the 1-Phosphate Group of Lipid A J. Biol. Chem., August 26, 2005; 280(34): 30214 - 30224. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. M. Wurfel, W. Y. Park, F. Radella, J. Ruzinski, A. Sandstrom, J. Strout, R. E. Bumgarner, and T. R. Martin Identification of High and Low Responders to Lipopolysaccharide in Normal Subjects: An Unbiased Approach to Identify Modulators of Innate Immunity J. Immunol., August 15, 2005; 175(4): 2570 - 2578. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
Z. Orinska, E. Bulanova, V. Budagian, M. Metz, M. Maurer, and S. Bulfone-Paus TLR3-induced activation of mast cells modulates CD8+ T-cell recruitment Blood, August 1, 2005; 106(3): 978 - 987. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. Chan, L. Li, C. E. McCall, and B. K. Yoza Endotoxin Tolerance Disrupts Chromatin Remodeling and NF-{kappa}B Transactivation at the IL-1{beta} Promoter J. Immunol., July 1, 2005; 175(1): 461 - 468. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 Y. C. Luiking, M. M. Hallemeesch, W. H. Lamers, and N. E. P. Deutz NOS3 is involved in the increased protein and arginine metabolic response in muscle during early endotoxemia in mice Am J Physiol Endocrinol Metab, June 1, 2005; 288(6): E1258 - E1264. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. M. Zughaier, S. M. Zimmer, A. Datta, R. W. Carlson, and D. S. Stephens Differential Induction of the Toll-Like Receptor 4-MyD88-Dependent and -Independent Signaling Pathways by Endotoxins Infect. Immun., May 1, 2005; 73(5): 2940 - 2950. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
O. E. Sorensen, D. R. Thapa, A. Rosenthal, L. Liu, A. A. Roberts, and T. Ganz Differential Regulation of {beta}-Defensin Expression in Human Skin by Microbial Stimuli J. Immunol., April 15, 2005; 174(8): 4870 - 4879. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
W. J. Kaiser and M. K. Offermann Apoptosis Induced by the Toll-Like Receptor Adaptor TRIF Is Dependent on Its Receptor Interacting Protein Homotypic Interaction Motif J. Immunol., April 15, 2005; 174(8): 4942 - 4952. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. L. Peterson, K. Ault, M. J. Kremer, A. J. Klingelhutz, C. C. Davis, C. A. Squier, and P. M. Schlievert The Innate Immune System Is Activated by Stimulation of Vaginal Epithelial Cells with Staphylococcus aureus and Toxic Shock Syndrome Toxin 1 Infect. Immun., April 1, 2005; 73(4): 2164 - 2174. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. Kalis, M. Gumenscheimer, N. Freudenberg, S. Tchaptchet, G. Fejer, A. Heit, S. Akira, C. Galanos, and M. A. Freudenberg Requirement for TLR9 in the Immunomodulatory Activity of Propionibacterium acnes J. Immunol., April 1, 2005; 174(7): 4295 - 4300. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. Jimenez, E. Belcher, |
